Adrian Newman-Tancredi

Chief Executive Officer

Country flagFrance

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Adrian Newman-Tancredi is the Chief Executive Officer at Neurolixis. He is based in France and specializes in pharmacological MRI methodologies. His recent research focuses on investigating the functional selectivity of 5-HT1A receptor biased agonists.

Articles (1)

Year:

2020

Collaborators (2)

Jean-Baptiste Langlois

CNRS Délégation Alpes

FRANCE
View details

Luc ZIMMER

Professor of Pharmacology (PU-PH)

Université Claude Bernard Lyon 1

FRANCE
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.